Renaissance Technologies (RenTech)'s OM Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 222,075 shares of Outset Medical, Inc. (OM) worth $852,768, representing 0.00% of the portfolio. First purchased in 2021-Q4, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in OM, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 176,870 shares. Largest reduction occurred in Q2 2024, reducing 30,159 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Outset Medical (OM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Outset Medical (OM) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +176,870 | Add 391.26% | 222,075 | $3.84 |
| Q4 2025 | +4,745 | Add 11.73% | 45,205 | $3.71 |
| Q3 2025 | +16,600 | Add 69.57% | 40,460 | $14.12 |
| Q2 2025 | -17,346 | Reduce 42.10% | 23,860 | $19.21 |
| Q1 2025 | -4,577 | Reduce 10.00% | 41,206 | $11.06 |
| Q4 2024 | +42,171 | Add 1167.52% | 45,783 | $16.65 |
| Q3 2024 | +3,612 | New Buy | 3,612 | $10.15 |
| Q2 2024 | -30,159 | Sold Out | 0 | $0.00 |
| Q1 2024 | +7,999 | Add 36.10% | 30,159 | $33.29 |
| Q4 2023 | +14,227 | Add 179.34% | 22,160 | $81.14 |
| Q3 2023 | +7,933 | New Buy | 7,933 | $163.24 |
| Q2 2023 | -9,640 | Sold Out | 0 | $0.00 |
| Q1 2023 | +7,507 | Add 351.95% | 9,640 | $0.28 |
| Q4 2022 | -1,194 | Reduce 35.89% | 2,133 | $0.39 |
| Q3 2022 | +3,327 | New Buy | 3,327 | $238.95 |
| Q2 2022 | -3,427 | Sold Out | 0 | $0.00 |
| Q1 2022 | -10,566 | Reduce 75.51% | 3,427 | $681.06 |
| Q4 2021 | +13,993 | New Buy | 13,993 | $691.35 |
Renaissance Technologies (RenTech)'s Outset Medical Investment FAQs
Renaissance Technologies (RenTech) first purchased Outset Medical, Inc. (OM) in Q4 2021, acquiring 13,993 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Outset Medical, Inc. (OM) for 18 quarters since Q4 2021.
Renaissance Technologies (RenTech)'s largest addition to Outset Medical, Inc. (OM) was in Q1 2026, adding 222,075 shares worth $852,768.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 222,075 shares of Outset Medical, Inc. (OM), valued at approximately $852,768.
As of the Q1 2026 filing, Outset Medical, Inc. (OM) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Outset Medical, Inc. (OM) was 222,075 shares, as reported at the end of Q1 2026.